Skip to main content
. 2020 Jan 28;17:100190. doi: 10.1016/j.obmed.2020.100190

Table 2.

COC Urinary rate by sex, age, severity of T2DM, comorbidities, and treatment type.

COC Urinary
Variables Rate (%) OR P-value
Sex Men (ref.) 10.5 2.65 <0.0001
Age (years) 18–64 (ref.) 9.0
65–74 12.6 1.47 0.011
75–84 22.2 2.9 <0.0001
Above 85 27.5 3.84 <0.0001
Severity of T2DM Stage 1 (ref.) 24.4
Stage 2 4.8 0.16 <0.0001
Stage 3 24.7 1.02 0.9445
Comorbidities NUT82 (ref.) 14.6
CVS13 21.5 1.6 0.0005
NUT02 16.8 1.18 0.2614
CVS11 14.8 1.02 0.9266
NEU04 22.7 1.72 0.0008
CVS09 20.7 1.52 0.0423
RES15 24.6 1.91 0.0006
GUS08 23.1 1.76 0.0034
RES83 25.5 2.01 0.0003
RES24 18.5 1.32 0.4
GIS27 28.2 2.29 0.0031
RES13 8.3 0.53 0.5468
GIS30 12.5 0.84 0.8133
Treatment type Surgical (ref.) 4.8 6.52 <0.0001
Medical 24.6

COC Urinary, urinary tract infection after procedure; NUT82, lipid abnormalities; CVS13, essential hypertension; NUT02, obesity; CVS11, coronary artery disease without prior coronary revascularization; NEU04, cerebrovascular disease; CVS09, congestive heart failure; RES15, pneumonia: bacterial; GUS08, renal failure; RES83, other disorders of the respiratory system; RES24, rhino, adeno, and corona virus infections; GIS27, neoplasm, malignant: colon and rectum; RES13, neoplasm, malignant: lungs, bronchi, or mediastinum; GIS30, neoplasm, malignant: stomach. Rate (%) = Total number of patients with infection/sum of patient at risk without infection and at risk with infection *100, Abbreviation: T2DM, type 2 of diabetes mellitus; OR, odds ratio; ref., reference group.